Tag Archives: Blood

Gut Microbiome Controls Blood Glucose Levels Through the Liver

Gut microbes influence blood glucose levels by acting directly on the liver, not by regulating the energy expenditure of specialized fat tissues, which use glucose as fuel to create heat, according to a study in mice by Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings, published Feb. 20 in Cell Metabolism, suggest modifying gut microbes may… Read More »

Healing Hope: A Gel Derived From Blood

Healing Hope: A Gel Derived From Blood : There is a gel that is made from a patient’s blood that can drastically speed the healing process of chronic wounds, especially ulcers that occur on the feet of diabetic patients. When these ulcers are treated with the gel they are far more likely to have a healthy… Read More »

Celgene taps Bristol-Myers salesforce to bolster key blood cancer launches

SAN FRANCISCO—After agreeing last year to swallow Celgene for a whopping $ 74 billion, Bristol-Myers Squibb trumpeted the potential of pairing its solid-tumor expertise with Celgene’s hematology expertise to create a leading cancer drugmaker. But the legacy BMS business had some hematology expertise of its own—and Celgene’s taking advantage, said Nadim Ahmed, the now-combined company’s… Read More »

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions Print this page SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the… Read More »